Nucleotide analogs

Patent metadata

Field	Value
Publication number	US-9801884-B2
Application number	US-201615171935-A
Country	US
Kind code	B2
Filing date	Jun 2, 2016
Priority date	Sep 15, 2014
Publication date	Oct 31, 2017
Grant date	Oct 31, 2017

Abstract

Disclosed herein, inter alia, are acyclic nucleotide analogs and methods of using an acyclic nucleotide analog for treating and/or ameliorating a papillomavirus infection.

First claim

What is claimed is:

1. A compound selected from the group consisting of:

2. The compound of claim 1 with structure:

3. The compound of claim 1 with structure:

4. The compound of claim 1 with structure:

5. The compound of claim 1 with structure:

6. The compound of claim 1 with structure:

7. The compound of claim 1 with structure:

8. The compound of claim 1 with structure:

9. The compound of claim 1 with structure:

10. The compound of claim 1 with structure:

11. The compound of claim 1 with structure:

Assignees

• Univ California

Inventors

• Hostetler Karl Y
• Beadle James R
• Valiaeva Nadejda

Classifications

• A61P35/00

  Antineoplastic agents · CPC title

• A61K33/42

  Phosphorus; Compounds thereof · CPC title

• C07F9/40 Primary

  Esters thereof · CPC title

• C07F9/6561

  containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings · CPC title

• A61P31/20

  for DNA viruses · CPC title